How This Beaten-Down Quantum Stock Could Rise 150%
Needham starts coverage of Pasqal at Buy, with analyst David Williams pointing to the quantum developer’s commercial traction and strong balance sheet.
Needham starts coverage of Pasqal at Buy, with analyst David Williams pointing to the quantum developer’s commercial traction and strong balance sheet.